Literature DB >> 10352592

CT-monitored percutaneous cryoablation in a pig liver model: pilot study.

F T Lee1, S G Chosy, P J Littrup, T F Warner, J E Kuhlman, D M Mahvi.   

Abstract

PURPOSE: To determine the safety and feasibility of percutaneous cryoablation with computed tomographic (CT) guidance in a pig liver model.
MATERIALS AND METHODS: Nine angiographic balloons (mean diameter, 9 mm) were placed in the livers of seven domestic pigs (mean weight, 30.0 kg +/- 14.0 [SD]) as tumor-mimicking lesions. By using ultrasonographic and CT guidance, two 2.4- or 3.0-mm cryoprobes were placed flanking the balloon, and a 15-20-minute freezing process was performed. Hemostasis was achieved by placing absorbable cellulose fabric down the probe tract. After 24-96 hours, animals were sacrificed, and their livers were removed and were sectioned axially at 5-mm intervals for comparison with CT images.
RESULTS: All animals survived the procedure without complication. No serious hemorrhage was found in any case. Ice balls were readily visualized at CT because they appeared as areas of decreased attenuation (1.0 HU +/- 20.7) when compared with areas of normal liver (48.2 HU +/- 6.3, P < .05). The mean ablative margin was 1.7 cm, and only one of nine cases, the one with probe failure, had a positive margin. Beam-hardening artifact from the metal probes was present but did not interfere with the procedure. Ice-ball size and shape corresponded closely to the area of necrosis determined at histopathologic analysis.
CONCLUSION: CT-monitored percutaneous cryoablation is feasible and safe in this pig liver model.

Entities:  

Mesh:

Year:  1999        PMID: 10352592     DOI: 10.1148/radiology.211.3.r99jn29687

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

1.  The author replies

Authors: 
Journal:  Surg Endosc       Date:  2000-02       Impact factor: 4.584

Review 2.  Thermal Ablation of Bone Metastases.

Authors:  Michael R Moynagh; A Nicholas Kurup; Matthew R Callstrom
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

Review 3.  Clinical utility of virtual noncalcium dual-energy CT in imaging of the pelvis and hip.

Authors:  Francis I Baffour; Katrina N Glazebrook; Jonathan M Morris; Gregory J Michalak; Joel G Fletcher; Shuai Leng; Cynthia H McCollough
Journal:  Skeletal Radiol       Date:  2019-05-30       Impact factor: 2.199

Review 4.  Current State of Tumor Ablation Therapies.

Authors:  Christopher W Bailey; Malcolm K Sydnor
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

Review 5.  Ablation of Intrahepatic Cholangiocarcinoma.

Authors:  Jennifer Sweeney; Nainesh Parikh; Ghassan El-Haddad; Bela Kis
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

6.  Lethal isotherms of cryoablation in a phantom study: effects of heat load, probe size, and number.

Authors:  Peter J Littrup; Bassel Jallad; Vinaya Vorugu; Gunnar Littrup; Brandt Currier; Mikhail George; Donald Herring
Journal:  J Vasc Interv Radiol       Date:  2009-08-19       Impact factor: 3.464

7.  Characterization of a CMOS sensing core for ultra-miniature wireless implantable temperature sensors with application to cryomedicine.

Authors:  Ahmad Khairi; Chandrajit Thaokar; Gary Fedder; Jeyanandh Paramesh; Yoed Rabin
Journal:  Med Eng Phys       Date:  2014-07-04       Impact factor: 2.242

8.  Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why?

Authors:  J Louis Hinshaw; Meghan G Lubner; Timothy J Ziemlewicz; Fred T Lee; Christopher L Brace
Journal:  Radiographics       Date:  2014 Sep-Oct       Impact factor: 5.333

Review 9.  Percutaneous Cryoablation for Liver Cancer.

Authors:  Li-Zhi Niu; Jia-Liang Li; Ke-Cheng Xu
Journal:  J Clin Transl Hepatol       Date:  2014-09-15

10.  Unresected Breast Cancer: Evolution of Imaging Findings Following Cryoablation.

Authors:  Jennifer T Bergin; Gale A Sisney; Fred T Lee; Elizabeth S Burnside; Lonie R Salkowski
Journal:  Radiol Case Rep       Date:  2015-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.